A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in the United Kingdom

14/10/2015
23/04/2024
EU PAS number:
EUPAS11299
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

16647_THIN_Rivaroxaban protocol

English (797.48 KB - PDF) View document
Study results
Study results

Combined Report_16159_16646_16647_17543_EU PAS Abstract_Redacted_V1.0_2020-11-26

English (152.16 KB - PDF) View document
Study report
Study report

16647_Progress report_v1.0._2019-01-28

English (93.11 KB - PDF) View document

Xarelto PASS - Combined Report_16159_16646_16647_17543_redacted_final

English (592.92 KB - PDF) View document
Other information
Study, other information

Xarelto PASS - Combined Report_16159_16646_16647_17543_redacted_final.pdf

English (592.92 KB - PDF) View document